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It is well known that Ia+ accessory cells are required for presenting antigens to
T lymphocytes . This is especially true ofCD4+ helper T cells which recognize an-
tigens together with Ia or class II MHC products (1, 2) . There is recent evidence
that Ia+ dendritic cells directly stimulate CD8+ cytotoxic T cells (3) . SinceCD4+
cellswere not detected in the cultures, and since neither anti-lanor anti-CD4mAbs
blocked dendritic cell function, it appeared that class I molecules on dendritic cells
were stimulating CD8 + cells directly (3) . Therefore expression of Ia can serve as
a marker for active APC (dendritic cells) but may not be required in the presenta-
tion of class I MHC products .
While Ia+ and la- macrophages (MO)t typically are inactive as independent pre-
senting cells in several responses (4-7), including the response of allogeneic CD8+
cells (3), MO are able to enhance the MLR that is initiated by small numbers of
dendritic cells (6) . This enhancementmightbedue to the secretion of soluble factors
from MO, which then potentiate dendritic cell function . Higher doses ofMOB sup-
press dendritic cell function (6, 7) .
Here we describe experiments in which we try to enhanceMO presentation of
alloantigens in the absence of dendritic cells . Previously we tested interferons and
noted that these cytokines could up or down regulate presentation to sensitized T
lymphoblasts, but did not makeMO stimulatory for restingT cells (6, 8) . We now
identify a combination of stimuli that are effective in the primary MLR. One is
to treat MO with neuraminidase (Nase), which enables the MO to bind T cells ;
another is to add exogenous IL-2 . These additions allow the Mfg to stimulate class
I-restricted, CD8+ cells directly, but not class II-restricted, CD4+ lymphocytes .
The findings draw some distinctions between the mechanism of action of dendritic
cells and MUD, as well as the stimulatory requirements for antigen-specific, CD8+
and CD4 + lymphocytes .
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education,
Science, and Culture ofJapan, and by a Naito Foundation Research Grant for 1987 .
1 Abbreviations used in thispaper: MO, macrophages ; Nase, neuraminidase ; PEC, peritoneal exudate
cells; SAC, spleen adherent cells ; TGC, thioglycollate medium .
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Materials and Methods
Mice. Female mice were used at 7-12 wk old. C3H/HeSIc, BALB/c, (BALB/c x
DBA/2)F, (CxD2 Fl), and A/J mice were from Shizuoka Agricultural Cooperative Associa-
tion for Laboratory Animals (Shizuoka, Japan). A.TL and A.TH mice originally were given
to us by Dr. T. Hamaoka, Osaka University (Osaka, Japan) and then bred in our facility.
Reagents.
￿
We were generously provided with murine rIFN-y by the Research Institute
for Shionogi Pharmaceutical Co. Ltd., Osaka, Japan, and with human rIL-2 by Central Re-
search Labs, Ajinomoto Co. Inc., Kawasaki, Japan. We used the following mAbs (fromAmer-
ican Type Culture Collection, Rockville, MD) as culture supernatants to stain or to deplete
the corresponding cell populations in the presence of rabbit complement: 10.2 .16 (anti-I-A');
M5/114.15.2 (anti-I-Ab'd.q, I-Ed.k); 11-4.1 (anti-H-2Kk); HO-2.2 (anti-Lyt-2.2); 3.155 (anti-Lyt-
2); 53-6.72 (anti-Lyt-2); GK 1.5 (anti-=4); HO-13-4 (antiThy-1.2); andJlld.2 (anti-B cell).
We purchased fluoresceinated rat mAb to mouse Lyt-2, CD8, and phycoerythrin-conjugated
anti-L3T4, CD4 (Becton Dickinson Immunocytometry Systems, Mountain View, CA), goat
F(ab')2 anti-mouse IgG + IgM, FITC-conjugate (Tago, Inc., Burlingame, CA); FITC-
avidin (Vector Laboratories, Inc., Burlingame, CA); neuraminidase (type X; Sigma Chem-
ical Co., St. Louis, MO). The culture medium, which had < 1 pg/ml LPS, assessed by a chro-
mogenic endotoxic-specific assay (,Endospecy; Seikagaku Kogyo Co. Ltd., Tokyo), was RPMI
1640 (Nissui Seiyaku Co. Ltd., Tokyo) supplemented with 10% FCS (HyClone Laboratories,
Logan, UT), penicillin (100 U/ml), streptomycin (100 ug/ml), 50 PM 2-ME, 1 lag/ml indo-
methacin, and 10 mM Hepes.
Cells.
￿
MO were adherent peritoneal exudate cells (PEC) from mice injected with Brewer's
thioglycollate medium (TGC) (Difco Laboratories, Detroit, MI), which had 11 ng/ml LPS,
4 d previously. PEC were irradiated with 650 rad to prevent the growth of contaminating
fibroblasts, and were plated into 24-well plates (A/S Nunc, Kamstrup, Roskilde, Denmark).
However, the dose of 650 rad did not alter the viability, expression of Ia antigens, or MLR
stimulating activity relative to unirradiated cells. After 2-3 h, nonadherent cells were re-
moved by washing. The adherent MO were tested outright (Table VI), but in most experi-
ments they were cultured 4 d in 1 ml medium with or without 12.5 U/ml rIFN-y to prepare
rIFN-y' and rIFN-y- MO respectively. At least 8017o of the former expressed Ia as shown by
indirect immunofluorescence in each experiment(8). Expression ofH-2K classI MHC prod-
ucts also was upregulated by IFN-y (Fig. 1), and upregulation of H-2D has been reported (4).
T cells were prepared by passing a mixed suspensions of spleen and mesenteric lymph
node over nylon wool and treating the nonadherent cells with mAb to Ia and Jlld in the
presence of rabbit complement. CD4' and CD8' T cell subsets were made by depleting
Lyt-2 (HO-2.2 or 3.115) and L3T4 (GK 1.5) cells by cytotoxicity, respectively. A final step,
to remove dead cells and residual accessory cells, was to sediment the populations (5-8 x
10') in 5 ml of 65% Percoll at 900 g for 25 min at 4°C.
B cells were Sephadex G-10 (Pharmacia Fine Chemicals, Uppsala, Sweden) nonadherent
spleen cells that were depleted for T cells by treatment with antiThy-1.2, L3T4, and Lyt-2
mAbs and complement. Small B cells, -30 0 Io of the total, were obtained from the pellet frac-
tion after centrifugation in 65% Percoll (see above).
Spleen adherent cells (SAC), a mixture of MO and dendritic cells (9), were prepared by
adhering spleen for 2 h at 2 x 106/ml in 16-mm wells. Typically, 3-5 x 104 cells adhered.
Mixed Leukocyte Reaction. Mm were cultured in 1 U/ml Nase in serum-free RPMI 1640
medium containing 10 mM Hepes for 45 min at 37°C. After washing four times with RPMI
1640/10% FCS, the MO were X-irradiated (1,500 rad) and served as stimulators. Thus MOB
were actually irradiated twice; first at 650 rad to prevent fibroblast outgrowth, and second
at 1,500 rad for the MLR; but as mentioned above, the former treatment had no effect on
the results. SAC and B cells were also irradiated with 1,500 rad before use in the MLR. 2
x 106 responder high density T cells were cultured with or without rIL-2 in 24-well plates
for 82-88 h. The cultures were suspended and aliquots (0.2 ml) from each well were trans-
ferred in triplicate to 96-well flat-bottomed tissue culture plates (A/S; Nunc) to be pulsed
with 0.5 pCi [3Hlthymidine (50 Ci/mM; ICN Radiochemicals, Irvine, CA) for 6 h. Similar
results were obtained ifthe original macrocultures were pulsed with [3Hlthymidine and the
aliquots were then taken for harvesting. The data represent the means of triplicate assays
from duplicate wells.V
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FIGURE 1.
￿
Expression of MHC class I and II antigens on the MO cell surface. IFN-y- (left)
and IFN-y' (right) MO from C3H/He mice were stained with anti-class I (H-2Kk; 11-4.1, thick
solid line) or anti-class II (Ia; 10.2.16, broken line) mAb. Cells unstained, or stained with FITC-
second antibody alone (dotted andthin solid lines), served as controls.
CTL Assay.
￿
P815 (H-2d), X5563 (H-2k), and YAC-1 (H-2a) cell lines were labeled with
Na"Cr04, 104 cells were added as targets to graded doses of effector cells in 96-well round-
bottomed plates (A/S Nunc). After 5 h, the plate was centrifuged for 10 min at 400 g and
the supernatants were collected to measure released isotope. Spontaneous release was deter-
mined in wells without effector cells, and maximal release in wells treated with 0.1 ml 0.1170
Triton X-100 for 30 min before the end of the assay. Percent specific lysis was calculated as:
100 x [(experimental - spontaneous release)/(maximal - spontaneous release)] .
Cyto,Jtuorography.
￿
Cells were analyzed (FACStar, B-D Automated Immunochemistry, Salt
Lake City, UT), before or after the MLR culture, with FITC-anti-Lyt-2 and PE-anti-L3T4.
Controls were unstained cells. Dead cells were gated out after staining with ethidium bro-
mide. Cell size was monitored by forward light scattering.
To analyze MO in the FAGS, PEC were cultured in Teflon containers for 4 d in the pres-
ence or absence of IFN-y. After washing, the cells were incubated with 100 gg/ml human
gamma globulin for 30 min at 4°C to block Fc receptors before staining. Lymphocytes were
gated out on the basis of their distinct forward and side light scattering properties.
Binding of T Cells to MO .
￿
IFN-y treated, TGC-MO (2 x 105) on 13-mm glass coverslips
were treated without or with Nase and cultured with 5-6 x 106 T cells in 24-well plates for
2-3 h at 37°C. After washing unbound T cells, the coverslips were fixed with 1.25% parafor-
maldehyde for 20 min at room temperature and observed under an inverted phase contrast
microscope.
Results
Effect of Nase on the Stimulatory Activity of Macrophages.
￿
We previously noted that
Ia+, TGC-MO were inactive for stimulating an allogeneic MLR in bulk T cells
(6). This might have been due to an excess of sialic acid on macrophage la antigens,
as suggested previously to explain the inactivity of Ia+ B cells (10, 11). Therefore,
we treated rIFN-y+ and rIFN-y- MO with Nase before use as stimulators in the
primary MLR. No stimulation was observed in the C3H [H-2k] vs. BALB/c (H-2d)
combination (Table I) .
Exogenous IL-2 Synergizes with Nase Treatment to Induce an MLR.
￿
One defect in MO
as presenting cells may be an inability to induce the production of T cell growth
factors like IL-2. Therefore, IL-2 was added to the MLR. We also monitored the
effects of MO pretreatment with rIFN-y, which upregulates class I and II MHC
products (Fig. 1), together with Nase (Table I, Fig. 2 A). HL-2 itself induced T cell
proliferation beginning at a dose of 300 U/ml (Fig. 2). At a lower dose, 30 U/ml,
which was just maximal for this preparation in an IL-2 bioassay, IL-2 amplified the1446
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TABLE I
Macrophages Stimulate Allogeneic, But Not Syngeneic, T Cell Proliferation in the Presence of rIL-2
2.5 x 105 PEC were cultured in the presence or absence of 12 .5 U/ml rIFN-y for 4 d in 16-mm-diam wells.
The IFN-y - and IFN-y+ M0 were treated with Nase. SAC were -3 x 104 SAC prepared by adhering 2 x
106 spleen cells in 16-mm wells for 2 h. 2 x 106 la - bulk T cells were cultured with M0 or SAC for 79 h
in the presence or absence of 100 U/ml human rIL-2. Then, 0.2-ml aliquots were transferred into 96-well
plates and pulsed with 1 gei[3H]TdR for 6 h.
MLR inthe presence ofMO, especially rIFN-y-treated cells (Fig 2A, Table I). How-
ever, theMOhad tohave been treatedwith Nase beforehand and onlyan allogeneic
vs. syngeneic MLR was induced (Table I). Therefore, Nase pretreatment and exog-
enous IL-2 together seem to be required for a primary MLR with allogeneic,
TGC-MO, while pretreatment with rIFN--t further enhances the response.
In The PresenceofIL-2, Nase-treated MacrophagesPresent ClassIMHC.
￿
To determine
if both class I and II MHC products could be presented by MO, MLRs were set
up with select strains including MHC recombinants. In Exp. A, Table II, T cells
from A/J mice (kkd) responded to MO from A.TH and CxD2F1, strains that differ
at both class I and II MHC loci. A.TL (skd) T cells responded to class I, H-2K-
disparate MO (A/J; kkd), but not class II-disparate MO (A.TH; ssd). In Exp. B,
Table II, A/J (kkd) MO stimulated C3H/He (kkk) that differ at the H-2D class I
locus. Exogenous IL-2 was required for these responses to class I (Table II). On
the otherhand mixtures ofspleen dendritic cells and MO induced strong prolifera-
tive responses across all MHC barriers, and exogenous IL-2was not essential(Table
II). Because of prior results (3, 9), stimulation by spleen adherent cells was likely
due to the dendritic cell component.
T Cell Subsets that Respond to Nase-treatedMacrophages plus IL-2.
￿
It is known that
CD4+ (Lyt-2 -) and CD8+ (L3T4-) T cells are restricted to antigens presented on
MHC class II and I products, respectively (2). Given the data that Nase-treated
MO stimulated across a class I MHC barrier, the MLRs were performed with en-
riched CD4+ and CD8+ T cells as responders. There were prominent responses
by CD8+ T cells as long as the MO were treated with Nase (not shown) and sup-
plemented with low doses of rIL-2 (30 U/ml; Table III). The CD4+ lymphocytes
did notrespond to MO, even with IFN-y, Nasetreatment andexogenous rIL-2 (Table
Stimulator cells:
Obtained from : Cell type Nase treatment
Proliferative
C3H/He T
- rIL-2
response
cells
+ rIL-2
([3H]TdR incorporation)
BALB/c T cells
- rIL-2 + rIL-2
cpm cpm
C3H/He IFN-y - M0 - 181 892 23 409
+ 309 284 1,215 2,293
IFN-y+ Mo - 146 1,096 57 454
+ 166 2,647 1,452 16,613
SAC - 1,342 ND 25,537 ND
BALB/c IFN-y- Mo - 137 1,671 75 92
+ 1,531 2,235 85 260
IFN-y ` Mo - 494 290 56 159
+ 486 13,497 198 693
SAC - 16,686 ND 1,605 ND
None 161 2,083 62 418HIRAYAMA ET AL.
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TABLE II
Neuraminidase-treated Macrophages Stimulate the Proliferation of MHC Class
I-incompatible T Cells in the Presence of rIL-2
2 x 106 la - bulk T cells were cultured with SAC or with IFN-y+, Nase-treated M0 in the presence or ab-
sence of 100 U/ml rIL-2 in 16-mm-diam wells. Data are means of triplicate assays of duplicate cultures for
MLRs at 80-86 h, as in Table I .
III, Fig. 2 B). SAC served as a positive control, inducing strong responses in the
CD4+ subset. The weak responses ofCD4+ T cells to MO was not due to different
kinetics of the MLR in this subset (Fig. 3).
PhenotypeofProliferating TCells by Cytofluorography.
￿
During the MLR, the prolifer-
atingT cells enlarge and these blasts can be distinguished on the basis ofincreased
forward light scattering. When MO were treated with Nase and used to stimulate
CD8+ cells in the presence ofIL-2, blasts were detected and these were all stained
with anti-CD8 but not anti-CD4 mAb (Fig. 4). Blasts did not develop in the CD4+
MLR. However, when unseparated T cells were used as the responder population,
CD4+ as well as CD8+ blasts were noted (Fig. 4). Since purified CD4+ cells did
not respond to MO, thedata indicate thatthe presence ofa CD8 response somehow
potentiates the CD4 response.
Development ofCTL after Stimulation with Macrophages and IL-2.
￿
Since CD8+ cells
are the major cytolytic subset in the primary MLR, we evaluated ifC3H/He (kkk)
Tcells formed CTL when stimulated by IFN-,y+ MOB or spleen adherent cells from
class 1-disparate A/J (kkd) mice. Lytic cells specific for H-2D vs. H-2K targets did
develop. Nase treatment and exogenous IL-2 were required, and only allogeneic
T cells formed CTL (Table IV). The response ofenriched CD8+ cells was greater
than bulk T cells (Table IV). With exogenous IL-2, the Nase-treated MO were as
effective in inducing CTL as SAC in the absence of IL-2.
Contacts BetweenNase-treatedMacrophages and T Cells.
￿
When dendritic cells stimu-
lateTcells, thetwo celltypes remain in contact foraday ormore (12, 13). Allogeneic
Exp.
Stimulator cells:
Obtained from : Cell type
Proliferative response ([3H]TdR incorporation) by bulk
T cells from the indicated strain and MHC (KID)
A.TL (skd) A/J (kkd)
- rIL-2 + rIL-2 - rIL-2 + rIL-2
cpm cpm
A A.TH IFN-y+ M0 565 2,255 387 13,697
(ssd) SAC 38,320 ND 20,706 ND
A/J IFN-y+ Mo 1,447 31,726 86 1,711
(kkd) SAC 7,595 ND 917 ND
CXD2F, IFN-y+ Mo 979 12,938 866 14,938
(ddd) SAC 63,426 ND 55,611 ND
None 353 1,165 47 1,135
B C3H/He (kkk) CXD2Ft (ddd)
- rIL-2 + rIL-2 - rIL-2 + rIL-2
A/J IFN-y+ M0 864 21,882 1,220 22,927
(kkd) SAC 4,570 ND 15,378 ND
CXD2F, IFN-y+ M0 1,137 17,745 118 ND
(ddd) SAC 16,333 ND 206 ND
None 289 848 122 8251448
￿
PREFERENTIAL ACTIVATION OF CD8+ CELLS
TABLE III
Enriched CD8+, But Not CD4+, T Cells Respond to Allogeneic Macrophages in the Presence of rIL-2
Stimulator cells :
￿
Proliferative response ([3H]TdR incorporation)
Obtained
￿
Cell
￿
Nase
￿
Bulk T
￿
CD8` T
￿
CD4+ T
Exp.
￿
from:
￿
type
￿
treatment
￿
- rIL-2
￿
+ rIL-2
￿
- rIL-2
￿
+ rIL-2
￿
- rIL-2
￿
+ rIL-2
2 x 106 Ia - bulk, CD4+ (depleted of Lyt-2+ T cells) or CD8' (depleted of L3T4+ T cells) T cells from
C x 132F1 (H-2d, Exp. A) orC3H/He (H-2k, Exp. B) mice were cultured with stimulator cells in the presence
or absence of 100 U/ml rIL-2. The proliferative response was measured as [3H]TdR incorporation at 78-84
h. Each number represents the mean of triplicate assays of duplicate cultures.
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FIGURE 2.
￿
IL-2 requirement for allogeneic T cell proliferation stimulated by MO. (A) Ia bulk
T cells from CxDFI mice were cultured with IFN-Y" (--" --) or IFN-y' (--t-) TGC-MO from
C3H/He mice in the presence of graded dose of rIL-2 for 84 h. T cells cultured with rIL-2 in
the absence of MO (O) served as control. (B) Ia- bulk T cells (" , O), enriched CD4* (depleted
of Lyt-2' T cells; /, p) or CD8+ (depleted ofL3T4' T cells; A, A) from CxD2F1 mice were
cultured with (closed symbols) or without (open symbols) Nase-treated, IFN-y' TGC-MO from
C3H/He mice in the presence of graded doses of rIL-2 for 85 h. The proliferative response was
expressed as [3H]thymidine incorporation during the last 6 h of culture. Each point represents
the mean of triplicate assays ofduplicate cultures. rIL-2 alone induced significant T cell responses
at high doses.
cpm cpm cpm
A C3H/He IFN-y - M0 - 126 1,309 110 2,093 127 145
+ 175 5,012 467 9,766 123 281
IFN-y+ Mo - 107 3,118 117 4,646 127 953
+ 778 12,734 615 18,336 580 982
SAC - 31,639 ND 29,883 ND 27,046 ND
None 158 290 79 236 95 469
B A/J IFN-y+ Mo + 688 16,994 709 20,856 612 1,144
SAC - 8,857 ND 18,401 ND 1,440 ND
C3H/He IFN-y + M0 + 54 357 45 521 95 716
SAC - 877 ND 534 ND 1,233 ND
None 78 986 92 1,034 53 956E
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FIGURE 3.
￿
Kinetics of the proliferative response of T
cell subsets to Nase-treated, IFN-y` MO in the pres-
ence of rIL-2 vs. SAC. 2 x 106 la- bulk (O, ", O),
enriched CD8' (A, A, A), or CD4' ([I, ", [:])Tcells
were cultured with Nase-treated, IFN-y' MO in the
presence (closed symbols) or absence(open symbols) of 100
U/ml rIL-2, or SAC (symbols with dots). Each symbol
represents the mean of triplicate assays.
MOB do not bind T cells (3, 13), but we wondered if Nase-treated cells did. This
proved to be the case (Fig. 5). Both CD4+ and CD8+ T cells bound to Nase-treated
MOB. Ifthe nonadherent T cells were removed, some of the attached CD8' T cells
later proliferated, but the CD4' did not (9,091 vs. 385 cpm, respectively).
NaseandExogenousIL-2EffectsonMLR Stimulation byFreshM0
￿
2-h adherent, TGC-
elicited PEC were used to stimulate the MLR in bulk Tcells and in enriched CD4'
and CD8' subsets. In some cases, the PEC were treated with anti-Ia and comple-
ment to remove a subset of3-8°Io Ia' PEC. Very weak MLRs were observed with
all populations ofT cells, and Ia' cell depletion abolished the weak CD4' MLR
(Table V). However, if either Nase treatment or exogenous rIL-2 was included, an
MLR occurred, but primarily in the CD8' subset (Table V). When the same MO
were cultured for 4 d, it was again necessary to expose them to IFN-y, treat them
with Nase, and add IL-2 to observe sizable MLRs (Table V).
Effect ofNase and Exogenous IL-2 on B Cell-stimulatedMLRs.
￿
Like MO, small B
cells are inactive as MLR stimulators (10, 13-15). To determine ifB cells could be
renderedimmunogenic inamanner comparable toMO, thelymphocyteswere treated
with Nase and added to allogeneic CD8' or CD4' T cells plus or minus exoge-
nous IL-2. The results were comparable to the MO findings. Both Nase and IL-2
were required to observe an allogeneic MLR with foreign B cells, and only the
CD8' subset responded directly (Table VI).
Discussion
Aconsiderable amount ofliterature has shown that lymphoid dendriticcells (iso-
lated from lymphoid organs, blood, and lymph) actively stimulate an MLR. In the
mouse it has been shown that class I and II MHC products are presented (9) and
that purified CD4' and CD8' subsets respond (3). In contrast, most populations
ofMO and B lymphocytes, when depleted of dendritic cells, are weak stimulator1450
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FIGURE 4.
￿
BlastogenesisofCD8` T cells stimulated by Nase-treated, IFN-y+ Mo in the pres-
ence of exogenous rIL-2. CD8', CD4*, and bulk cells from CxD2F) mice were stained with
anti-CD8or anti-CD4 mAbs before culture(top panels). Thesubsets were cultured with 100U/ml
rIL-2 without or with Nase-treated MO from C3H mice for 85 h. At the end of culture, cells
were collected, washed, stained with anti-CD8 andanti-CD4 antibodies, and analyzed by FAC-
Star. Cell size was monitored by forward light scattering.HIRAYAMA ET AL.
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TABLE IV
Neuraminidase-treated, H-2D Disparate Macrophages
Stimulate the Generation of CTL in the Presence of rIL-2
2 x 106 la- bulk or CD8 ` T cells from C3H/He mice (kkk) were cultured with H-2D-disparate (A/J, kkd)
or syngeneic C3H/He, SAC, or Nase-treated, IFN-y' M0 in the presence or absence of 100 U/ml rIL-2 for
85 h in 16-mm-diam w( Us. At the end ofculture, cells were collected, washed, and mixed with52Cr-labeled
target cells in 96-well round-bottomed plates for the cytolytic assay . Maximum and spontaneous release of
5 'Cr were 5,414 cpm and 879 cpm in P815 (H-2d), and 15,230 cpm and 4,633 cpm in X5563 (H-2k), respec-
tively. Cytolysic activity against YAC-1 target cells never exceeded that against P815 (not shown).
cells across either MAC barrier and with either T cell subset as responders (3, 9).
The lack of stimulation by MO does not seem to be due to a suppressive activity.
While MO can suppress the MLR that is inducedbydendritic cells, we have shown
that appropriate doses ofMO actually enhance the MLR at very low doses ofden-
dritic cells (6). Also, MO present both class I (3) and II (8, 13) MHC products to
sensitized CD8+ and CD4+ lymphoblasts. Here we have succeeded in making MO
directly immunogenic, that is in the apparent absence of dendritic cells. The vari-
ables that were studied were pretreatment of the MO with rIFN-y and with Nase,
and the supplementation
￿
f the MLR with exogenous IL-2.
Lymphokines, especially rIFN-y, have a marked effect on the expression ofclass
II MHC products oninflammatory MO. When cultured in the absenceoflymphokine,
the levels ofla become undetectable on most cells, while in its presence, la is found
on most MO (4, 16) (Fig. 1). Lymphokines also upregulate class I MHC products,
although the latter are expressed constitutively (4, 17) (Fig. 1). In our studies,
rIFN-y+ MO were more active as stimulators, but IFN-y- cells had some activity
(Tables I, III, and IV). Our experiments do not permit us to determine ifthe effect
of rIFN-y is due to a greater expression of class I products or to some other vari-
able, such as production of an amplifying cytokine.
Mm treatment with Nase was essential for observing stimulation in the MLR
(Tables I and III; Fig. 2). In contrast, no enhancement ofMLR was observed when
responder T cells or stimulator dendritic cells were treated with Nase (not shown).
Addition ofthe Nase inhibitor (2,3-dehydro-2-deoxy-N-acethy-neuraminic acid, 2
mg/ml; Boehringer Mannheim Biochemicals, Indianapolis, IN) during the treat-
ment ofMO with Nase abrogated its enhancing effect on the MLR, while incuba-
Stimulator
Obtained
from:
cells :
Cells
rIL-2 in
culture Targets 30:1
Cytolysis (percent
Bulk T cells
10:1 3:1
specifiic S'Cr release)
CD8' T cells
30:1 10:1 3:1
A/J IFN-y+ Mo - P815 -0.3 0.2 1 .8 7 .6 -1 .8 1 .4
+ P815 59.5 35 .0 18.8 65 .8 44.9 31 .0
+ X5563 -0.7 0.5 0.7 5 .1 -0.4 0.8
SAC - P813 54.8 29 .3 18.1 65 .1 44.6 28 .7
C3H/He IFN-y+ Mo - P815 1 .7 2 .1 0.4 2 .2 3.0 1 .8
+ P815 1 .1 -0 .2 0.0 3 .7 1 .4 0.4
+ X5563 -0.9 1 .3 1 .0 5 .4 1 .2 1 .7
SAC - P815 2.4 3 .3 3.0 2 .2 1 .4 1 .6
None - P815 0.6 1 .5 1 .6 1 .8 1 .2 0.2
+ P815 1 .7 2 .0 1 .8 0.5 2.1 2.0
+ X5563 0.0 -0.8 0.9 -2.9 1 .9 -0.81452
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TABLE V
Stimulatory Activity of Fresh TGC-Md on Different T Cell Subsets
High density populations of la - bulk, CD8', and CD4' T cells were prepared from CXD2Ft mice. M0 were
adherent cells of PEC from C3H/He mice injected with thioglycollate medium 4 d previously. To remove
la' cells, PEC were treated with mAbs and complement before adhering. 2 x 105 M0, adjusted by mor-
phology under the microscope, were plated into 24-well plates (16-mm wells). After washing off nonadherent
cells, 2-h TBC-M0 were tested as stimulators, or replicates were cultured for 4 d in the presence or absence
of rIFN-y before use as stimulators. Proliferation was monitored by [3H]TdR incorporation between 79 and
85 h of culture.
tion of Nase-treated MO with Nase-inhibitor did not abolish stimulatory activity
(not shown). Therefore, it seems unlikely that the effects we observed were due to
Nase carryover.
The use ofNase was suggested by the workofCowing and colleagues, who found
that Nase enhanced stimulation by enriched populations of B cells (10, 11). They
suggested that Nase acted by reducing the amount of sialic acid on class II MHC
products, but it is possible that Nase modification ofother molecules allows the pre-
senting cell and T cell to contact each other (Fig. 5). Native B cells and MO do
not seem to form such contacts (3, 13, 18). It has been reasoned that one ofthe rate-
TABLE VI
Neuraminidase-treated, High Density B Cells Stimulate Allogeneic CD8' T Cells in the Presence of rIL-2
2 x 10'' responder T cells of CXD2F] mice were cultured with high density B cells from C3H/He mice .
The B cells were high density, T-depleted, Sephadex G10 nonadherent lymphocytes. After 79 h of culture,
aliquots of cells were transferred to 96-well plates and pulsed with [3H]TdR for 6 h. Each number represents
the mean of triplicate assays of duplicate cultures.
Stimulators Proliferative response ([3H]TdR incorporation)
Cell
preparation
Nase
treatment - rIL-2
Bulk T
+ HL-2
cpm
CD8 `
- HL-2
cpm
T
+ HL-2
CD4'
- HL-2
cpm
T
+ rIL-2
2 h TGC-M0 - 2,436 10,734 3,344 17,996 461 554
(la-) + 15,323 20,112 21,197 25,468 754 2,203
2 h TGC-M0 - 3,211 11,558 4,587 18,335 2,477 7,391
(untreated) + 14,678 19,635 19,233 26,221 4,890 10,232
IFN-y+ M0 - 312 3,349 148 4,412 177 871
+ 345 12,034 296 13,001 333 1,202
IFN-y - Mo - 412 2,238 326 2,946 288 496
+ 349 4,344 277 6,291 391 1,269
SAC - 32,387 NT 36,547 NT 31,875 NT
None 216 847 148 810 169 946
Stimulators Proliferative response ([3H]TdR incorporation)
Cell Nase Bulk T CD8 + CD4'
type Number treatments - HL-2 + rIL-2 - rIL-2 + rIL-2 - rIL-2 + rIL-2
B cells 2 x 106 - 253 1,765 59 7,034 368 1,033
+ 197 17,775 157 20,327 1,531 4,518
6.7 x 105 - ND ND 48 3,685 59 549
+ ND ND 75 11,421 321 1,158
SAC 3 x 104 - ND ND 34,739 ND 38,637 ND
None 246 464 78 336 94 2181454
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limiting steps in the MLR is the capacity of the allogeneic stimulator cell to form
stable conjugates with the responding T cell (13, 19). To date, lymphoid dendritic
cells are the principal cell type that can form such clusters in antigen-dependent
primary responses.
Clustering, however, does not seem sufficient for immunogenicity. Nase-treated
MO and small B cells still required exogenous IL-2 . By inference, then, one of the
distinguishing features of dendritic cells and MO as APC is that dendritic cells seem
capable of inducing the endogenous production of essential growth factors.
Together, the combined treatment with IFN-y, Nase, and IL-2 only renders the
MCP immunogenic for the CD8' subset. Resting CD4' T cells do not respond class
II-disparate MO (Table III), whereas the number of enlarged blasts in the CD8+
MLR was considerable (Fig. 4). This might indicate that CD8' cells differ in the
presenting cell requirements for the appearance ofthe IL-2-responsive state. In con-
trast, dendritic cells actively stimulate a state of IL-2 responsiveness in CD4' lym-
phocytes (13).
Although we were unable to triggr the CD4+ subset directly with MO, our studies
provide preliminary information that it may be possible to do so. Specificially, we
noted the development of CD4+ T blasts when the responding population contained
both CD8' and CD4+ T cells (Fig. 4). One possibility is that MO synthesize am-
plifying factors like IL-1 or IL-6, but that these factors are only released after the
development of CD8` CTL (Table IV), thus liberating cell-associated activating
factors for use by other MO.
Summary
Prior work has shown that purified, resident, and inflammatory peritoneal mac-
rophages are weak stimulators of the allogeneic MLR. We have identified condi-
tions whereby thioglycollate-elicited macrophages become stimulatory, but primarily
for the CD8+ T cell subset. The conditions were to treat the macrophages with
neuraminidase and to supplement the MLR with rIL-2. These treatments together
led to proliferative and cytotoxic responses by isolated CD8+ but not CD4' T cells.
Likewise when MHC-congenic strains were evaluated, an MLR was observed across
isolated class I but not class II MHC barriers. Pretreatment of the macrophages
with IFN-y further enhanced expression of class I MHC products and stimulatory
activity, but did not seem essential. While these treatments did not render macro-
phages stimulatory for an MLR in purified CD4+ cells, blastogenesis of CD4+ cells
was observed when the MLR involved bulk T cells. Small allogeneic B lymphocytes
behaved similarly to macrophages, in that pretreatment with neuraminidase and
supplementation with rIL-2 rendered B cells stimulatory for allogeneic, enriched,
CD8', but not CD4', T cells. Spleen adherent cells, which are mixtures of mac-
rophages and dendritic cells, stimulated both CD4+ and CD8+ T cells, and nei-
ther neuraminidase nor exogenous IL-2 was required. We think that these data sug-
gest that most macrophages and small B cellslack three important functions ofdendritic
cells: a T cell-binding function that can be remedied by neuraminidase treatment,
a T cell growth factor-inducing function that can be bypassed with exogenous IL-2,
and an IL-2 responsiveness function that is required by CD4' lymphocytes.HIRAYAMA ET AL.
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